Introduction
============

The most common cause of dementia, Alzheimer's disease (AD), is an age-influenced chronic neurodegenerative progression. It is characterized across multiple scales including subcellular molecular changes in axonal transport and tauopathies that alter microtubule (MT) structure, formation of internal and external neurofibrillary plaques or tangles, and disruption of inter-neural signaling leading to gradual loss of brain cognitive function.[@b1-ijn-13-3105],[@b2-ijn-13-3105] The health care costs related to AD both for the patient and caregivers are expected to exceed one trillion dollars by 2050.[@b3-ijn-13-3105] Further, with increasing longevity it is predicted that an astounding one in three individuals reaching 90 years of age will be affected. No broadly effective treatments or cures for AD yet exist for this complex disease and an improved understanding of collective molecular events leading to discrete outcomes underlying neurodegeneration is needed. A causative agent in AD is the disruption of amyloid-β (Aβ) function that results in altered calcium influx and elevated intracellular levels of calcium, and leads to signaling dysregulation for transport of neurotrophic factors, such as the critical brain-derived neurotrophic factor (BDNF).[@b4-ijn-13-3105],[@b5-ijn-13-3105] A new IEEE reference standard and mathematical model framework for Nano, Electrical, Molecular (NEMo) communication[@b6-ijn-13-3105] provides a platform to evaluate multiple interlinked events as a molecular communication network. Communication theory has also been applied to calculate the storage capacity of discrete bounded synapses.[@b7-ijn-13-3105] Our current approach uses a physical layer framework and its stack functions in an end-to-end model that links multiple discrete nano-molecular events to a specific outcome to generate new neurodegenerative disease insights.

The "calcium hypothesis of AD" proposes that aberrant Ca^2+^ signaling occurs prior to accumulation of MT destabilizing events such as hyper-phosphorylation of the MT-associated protein tau (MAP-tau) and observance of cognitive decline.[@b8-ijn-13-3105] A recent study of BDNF transport defects in neurons revealed a spatiotemporal progression of fast axonal transport (FAT) impairment that correlated with Ca^2+^ elevation and CaN activation occurring first in dendrites and subsequently in axons consistent with this hypothesis.[@b4-ijn-13-3105] Several membrane receptors with ion channels regulate the influx of Ca^2+^ into cells, including NMDA (N-methyl-D- aspartate) and AMPA (α-amino-3-hydroxy-5-methyl-iso-xazolepropionic acid) glutamate receptors and axonal voltage-gated Ca^2+^ channels (VGCCs), and are affected by amyloid beta oligomer (AβO) binding.[@b9-ijn-13-3105]--[@b11-ijn-13-3105] The increased influx of Ca^2+^ into neurons also triggers Ca^2+^-induced release from internal stores, further elevating cytoplasmic levels of Ca^2+^ and sets into play a cascade of events with CaN, PP1, and GSK3β that ultimately impacts kinesin cargo loading and neurotrophic factor transport and contributes to synapse failure.[@b12-ijn-13-3105]--[@b14-ijn-13-3105] These calcium-regulated events target FAT in axons through effects on 1) kinesin cargo binding and its transport and 2) effects on MT structure (MAP-tau hyper-phosphorylation). In this work, we model AβO-directed increase in intracellular Ca^2+^ levels through AβO action on multiple membrane Ca^2+^ ion channels (NMDA, AMPA, VGCC) and internally regulated calcium stores (ryanodine receptor; RyR) and including the downstream effect on kinesin cargo loading of BDNF-dense core vesicle (DCV) at the axon initial segment (AIS) and along the axonal MT network as shown in [Figures 1](#f1-ijn-13-3105){ref-type="fig"} and [2](#f2-ijn-13-3105){ref-type="fig"}.

Two current models are proposed in which AβOs dysregulate Ca^2+^ entry into neurons and elevate intracellular Ca^2+^ levels to cause neurodegenerative disease. This includes direct interaction of AβOs with calcium ion channels in neuron membranes to increase influx[@b15-ijn-13-3105]--[@b17-ijn-13-3105] as well as the ability of AβOs themselves to integrate into membranes to form small pores or larger channels of variable size and impact on nonspecific ion influx.[@b18-ijn-13-3105]--[@b20-ijn-13-3105] AβO pore/channel forming ability and size parameters are influenced by oligomeric form and amino acid sequence and by additional factors such as cholesterol and a-synuclein.[@b21-ijn-13-3105],[@b22-ijn-13-3105] In this study, we additionally evaluate changes in Ca^2+^ levels that can occur as a result of pore/channel formation by Aβ1-42 oligomers and the effect on DCV-BDNF axonal MT loading and transport. We apply data based on studies of multivariate analysis of pore size formation in vitro[@b17-ijn-13-3105] and single-channel analysis in xenopus oocytes[@b16-ijn-13-3105] that provides permeation and gating properties without the presence of interfering endogenous channels that could interact with AβOs.

In order to provide mechanistic insights relevant to Ca^2+^--MT spatiotemporal events for axonal transport by kinesins, we consider molecular details of axonal MT cytoskeleton organization that consists of multiple polar MTs and MT end joining gaps created by discontinuous overlapping of MT polar plus and minus ends interacting along the length of axons.[@b23-ijn-13-3105] This better represents the complexity of the axonal MT network in loading and transport dynamics in our communication model. In our simulation, we limit the degree of MT overlap to be minimal, but future simulations can vary gaps or include branching to mimic alternate normal or disease scenarios. The long-term goal is to continue to advance our molecular models of the axon to more fully incorporate the morphological and dynamic complexity as it becomes known, and to continue to compare normal and disease states. This is a bold endeavor as the complexity and computational power required are challenging. Additional axonal MT complexities not modeled here that could be incorporated in future iterations include MT severing and MT dynamic events, MAP regulators, MT organization differences within the axon length, growth cones and synapses, as well as additional ionic regulation at sites such as the nodes of Ranvier or axonal organelles not modeled here. Integration with other neuro-molecular computational models that evaluate discrete events, such as axonal stretch models of MAP-tau in traumatic brain injury,[@b24-ijn-13-3105]--[@b26-ijn-13-3105] or in order to predict morphological outcomes such as branching,[@b27-ijn-13-3105] are expected to provide additional synergistic insights and improve multiscale models that depend on a more relevant molecular-nano-microscale simulation of events.

Methods
=======

Mapping to the 1906.1 standard
------------------------------

The IEEE 1906.1 standard was developed by a multidisciplinary team to generate a common framework to aid interdisciplinary research in nanoscale communication networks and applies Shannon's rules of communication theory to biological events. Communication theory has previously been applied to study the organizing principles of multicellular systems.[@b28-ijn-13-3105] Our model in overview represents the communication signaling system inside a neuron under three basic components: transmitter, channel, and receiver. 1) The transmitter is comprised of two mutually independent sources, which generate calcium ions or BDNF molecules, both following Poisson distribution. These sources might correspond to the dendritic-soma calcium channels and receptors with ion channels or the nucleus, respectively, in a neuron. Ca^2+^ ions elevated in the neuron cytosol passively diffuse through the soma to the AIS region, whereas BDNF molecules (DCV-BDNF) are assumed to be unlimited in the soma but must be carried over the network of MT segments in DCV--BDNF--kinesin complexes utilizing energy in the form of ATP molecules. 2) The diffusing Ca^2+^ ions affect BDNF transport in the axons resulting in the disruption of FAT. A network of M/M/1 queues is used to model the BDNF transport along MTs. A modified conventional diffusion equation, taking into consideration the calcium buffering, is used to model Ca^2+^ diffusion. 3) The DCV-BDNF that will be traversing the MT segments accumulates near the front end of a receiver, defined here as the minus ends of multiple bundled MTs that act as gates for the next stage of MTs. These MT gates can be assumed to be active regions of DCV-BDNF-kinesin-MT loading for transport. It is assumed that the accumulated DCV-BDNF requires efficient clearance out of the AIS region of the neuron for active signaling. An optimization procedure using Lagrangian relaxation and subgradient heuristic is used to optimize the number of gates to minimize the clearance time of DCV-BDNF from the AIS region. In a nutshell, the model is a manifestation of calcium signaling events in the neuron taking into consideration multiple nano- to macroscale biological events with functional impact. In [Table 1](#t1-ijn-13-3105){ref-type="table"} we summarize advantages of our model that investigates a larger communication network, versus other models.

Utilizing a priori knowledge of the system description and biological components as described, a neuronal communication system is mapped with the IEEE 1906.1 standard physical layer framework functions as follows: Message carrierIn this study, the signaling molecules of interest are the BDNF molecules which are loaded into DCVs and transported by kinesin molecular motors.PerturbationThe "perturbation" component varies the properties of message carriers to represent a signal.[@b6-ijn-13-3105] Modulation is brought about by aberrant Ca^2+^ influx triggered by AβO ion channel and receptor binding or Aβ1-42 pore/channel formation. Inside a neuron, there exists internal calcium storage/release control from the ER and external control from surface plasma membrane receptors (AMPA, NMDA, VGCC, etc.) over the net Ca^2+^ cytosolic levels inside the neuron cells.MotionThe "motion" component describes movement of the message carrier under a thrust applied to it. Motion provides the necessary potential to transport information through a communication channel.[@b6-ijn-13-3105] For active transport, message carriers generate their own motion using chemical energy of ATP harnessed by molecular motors, and for passive transport, a concentration gradient in the propagation media facilitates transport. Ca^2+^ ions diffuse across a concentration gradient in the cytosol. Within the axon, DCV--BDNF--kinesin complexes are actively transported in an anterograde motion.FieldThe "field" component is responsible for the organized motion of message carriers. It can be thought of as a virtual waveguide in communications.[@b6-ijn-13-3105] Inside a neuron, MTs assembled in axons act as a sequence of guided media for BDNF transport. MTs are polar filaments with designated plus and minus ends.[@b29-ijn-13-3105] The directional motility of molecular motor proteins on MTs is governed by the field generated by polarized heterodimeric α-/β-tubulin subunits that underlie the MT structural polarity. For example, conventional kinesin and some of the additional kinesin-like protein (Klp) families are plus end-directed motors, whereas Dynein is minus end-directed as are kinesin-14 family members. Thus, the field component includes directional specificity of the motors.SpecificityThe "specificity" component relates to sensing or reception of a message carrier by a target such as interaction of DCV-BDNF with kinesin-MTs.[@b6-ijn-13-3105] The mapping to the 1906.1 standard and the functionalities of the framework components for our model are summarized in [Table 2](#t2-ijn-13-3105){ref-type="table"} and [Figure 3](#f3-ijn-13-3105){ref-type="fig"}.

Model description and solution scheme for the transmitter, channel, and receiver components
===========================================================================================

Transmitter model description
-----------------------------

In our model, the signaling components are the calcium ions and DCV-BDNF molecules. As these ions/molecules are independently generated inside a neuron, the transmitter is represented as two mutually independent discrete memoryless sources (DMS).[@b6-ijn-13-3105] The generation of each component in a DMS is independent of previous generations. The generation of Ca^2+^ ions or DCV-BDNF molecules can be modeled as renewal processes in which ions or molecules are generated randomly in time, and the superimposition of many renewal processes gives a Poisson process. Thus, in a given interval of time, the sources generate streams of Ca^2+^ ions and DCV-BDNF molecules following a Poisson distribution and the inter-arrival time or the time between successive generations is exponentially distributed.

Assumptions made for the sake of computational simplicity: The whole neuron system is confined to a two-dimensional plane. We realize that this may create some bias,[@b30-ijn-13-3105] but is necessary to simplify the current simulation.The effects of multiple sources of Ca^2+^ (RyR as an internal source and AMPA, NMDA, VGCC as sources[@b31-ijn-13-3105]) are incorporated in the model by independent Poisson merging ([Figure 2](#f2-ijn-13-3105){ref-type="fig"}). It means that the number of Ca^2+^ ions generated independently from these sources need to be added together.In addition to the dendritic and somatic channels, there also exist additional calcium channels in the nodes of Ranvier all along the axon.[@b32-ijn-13-3105] However, our model focuses on polar MTs in the AIS region, and the contribution of these channels can be neglected in new shorter myelinated axons as shown in [Figure 1](#f1-ijn-13-3105){ref-type="fig"}.We evaluate oligomeric Aβ1-42 pore/channel formation only without contributing factors such as cholesterol or α-synuclein. The BDNF referenced study[@b4-ijn-13-3105] also applies oligomeric Aβ1-42.We apply single pore/channel flux information from the xenopus oocyte model system that provides permeation and gating properties without the presence of interfering endogenous channels that could interact with AβOs. Influx rates of Aβ1-42 pore/channels of similar diameter are expected to be similar amongst different model in vivo systems.

### Solution scheme: Poisson-distributed random ion/molecule generation

We use Knuth's algorithm for generating Poisson-distributed random variables.[@b33-ijn-13-3105] The algorithm uses the fact that the inter-arrival time in Poisson process is exponentially distributed. The "number of arrivals" in an interval is counted by considering the times between arrivals and adding them up until the sum is greater than the time interval. The expected run time of the algorithm is proportional to ion/molecule generation rate λ (incoming rate in ion/nanosecond). Beginning with an average value of the generation rate (obtained from cited literature sources), a random value of ions/molecules is generated. The algorithm is described in the supplementary material (section "Knuth's algorithm"). To minimize the complexity of the BDNF protein generation and DCV loading for our model, the dynamics of BDNF molecule generation are not considered. A source, nucleus in this case, is considered to release BDNF molecules through the process of translation at fixed intervals of time, which follows Poisson distribution and then loading into DCVs occurs. The calcium ions and DCV-BDNF molecules generated in the transmitter are transported through channels by different mechanisms, which are described in the next section.

Channel and receiver model description
--------------------------------------

Transport through a molecular communication channel can be categorized into two types: broadcast mode and point-to-point mode. As described in the subsequent sections, both of these modes exist in the axons. Depending on the properties of channel mediums, there can be two types of transport processes. When signaling molecules are transported down a concentration gradient or by motion of the surrounding medium without any expense of energy, the motion is passive. On the contrary, self-propelled motion along a guided path using chemical energy of the cell constitutes active transport.

### Ca^2+^ diffusion

The Ca^2+^ ions coming from different cytoplasmic membrane sources diffuse through the soma to the AIS through the cytosol (channel) in a Brownian motion following the broadcast mode. The diffusion mechanism is passive, governed primarily by the concentration gradient of Ca^2+^ ions and no external energy is required. The calcium concentration depends upon the diffusion coefficient (D) and the characteristics of binding with other molecules, that is, Ca^2+^ buffering. We simply assume that the number of Ca^2+^ bound (*Ca*^2+^*~bound~*) molecules is directly proportional to the number of Ca^2+^ ions generated (*Ca*^2+^*~gen~*) or present at that instant.[@b34-ijn-13-3105]

*Ca*^2+^*~bound~*= *BCa*^2+^*~gen~*, where B is the proportionality constant which is defined as the ratio of bound to free calcium ions.

If *c*′ is the concentration of Ca^2+^ ions at any point at a distance *r*′ from the point of generation of the same and at time instant *t*′, then $$\frac{dc^{\prime}(r^{\prime},t^{\prime})}{dt^{\prime}} = \frac{D}{1 + B}\Delta^{2}c^{\prime}(r^{\prime},t^{\prime})$$where $\frac{D}{1 + B}$ is the effective diffusive coefficient and noted as *D~eff~* considering calcium buffering in the neuron.

Assuming the transmitter starts releasing Ca^2+^ ions at *t*′=0, the impulse function of the solution for the above equation is $$I(r^{\prime},t^{\prime}) = \frac{1}{{(4\pi D_{eff}t^{\prime})}^{3/2}}e^{- \frac{{r^{\prime}}^{2}}{(4D_{eff}t^{\prime})}}$$

Since the transmitter generates a train of bursts of Ca^2+^ ions following Poisson distribution, the solution to the above diffusion equation for a train of Ca^2+^ ion bursts of size *Q*′ ions spaced by a period *δt′* and started at *t′* =0 is $$\left. c^{\prime}(r^{\prime},t^{\prime}) = {\sum\limits_{i = 0}^{t^{\prime}/\delta t^{\prime}}{Q^{\prime}I(r^{\prime},(t^{\prime} - i\delta t^{\prime})) \approx \frac{1}{\delta t^{\prime}}}}{\int_{0}^{t^{\prime}}{Q^{\prime}I(r^{\prime},\tau)d\tau}} = \frac{Q^{\prime}}{4\pi D_{eff}r^{\prime}\delta t^{\prime}}for\ t^{\prime}\rightarrow\infty \right.$$

Considering short neurons (excluding regions that have nodes of Ranvier or axonal branching), the concentration gradient guides calcium ions through some distance into the region of the axon at the AIS. Through metabolic pathways described before, these ions affect kinesin motility and cargo binding, and consequently disrupt FAT. The active counterpart of the transport process, namely the ATP-driven transport of BDNF-loaded DCV cargoes by kinesin motors on MTs is modeled by implementing a network of queues that is clearly described in section "Molecular motors, MT organization, and dynamics in the axon".

### Molecular motors, MT organization, and dynamics in the axon

It is known that axonal MTs do not span the entire length of the axon as single continuous long tracks but are instead composed of multiple shorter segments with ends presumed to possess normal MT dynamic characteristics under growth or disease scenarios, capable of undergoing polymerization and depolymerization, as regulated by MAPs.[@b35-ijn-13-3105] In the current model, we consider the MTs to be non-dynamic (capped) although this can be modified in future models in which MAPs (tau, others) or MT severing proteins (such as katanin) may act to contribute to tauopathy disease mechanisms. These MT end junctional points are modeled here for the first time in evaluating transport to improve model predictability of normal and disease states for the current parameters and for future studies of tauopathies and other axonopathies.

On the MT track, multiple motor proteins are expected to be involved in transport, namely conventional kinesin and Klps, and Dynein.[@b29-ijn-13-3105] Kinesins are diversified into 14 different Klp families[@b36-ijn-13-3105] and harness the chemical free energy released by the hydrolysis of ATP to perform active transport, such as of BDNF.[@b37-ijn-13-3105] Two parameters, namely 1) average forward anterograde velocity and 2) cargo capacity (defined as the maximum number of BDNF molecules that can be accommodated within one DCV cargo) are defined in this model. For simplicity, we consider only one type of kinesin motor protein so that the directional motility and velocity remain identical for all. Current reviews[@b38-ijn-13-3105] highlight that the movement of the cargoes driven by the molecular motor proteins on the MT track could be modeled as a random process consisting of random memoryless forward and reverse steps. The cumulative effects of the steps produce a resultant average forward velocity (v) of typically 800 nm/s in the case of the motor protein Klp-1 (conventional kinesin).[@b29-ijn-13-3105] During anterograde motion, the motor performs a power stroke by harnessing the energy from ATP that results in active transport. The typical length (l) units of MT segments in the model are defined on the order of micrometers. MTs are oriented in the axon with their minus ends toward the soma of the neuron and AIS and their plus ends distal to the axonal body and terminal synapse. We assume that the length of each polar MT segment from the minus end to plus end is finite, where the arriving molecular motors can be accumulated and distributed accordingly with the appropriate rates.

### DCV-BDNF transport and modulation due to calcium signaling

The BDNF molecules, generated by the transmitter, are loaded into DCVs and picked up by molecular motors at the AIS region. They arrive at the first MT segment following a Poisson distribution with an average arrival rate of λ packets/s where packets represent the DCV carrying BDNF molecules. As stated previously, MTs are polar filaments, each one having minus- and plus-end domains on either side across which anterograde motors traverse. The DCV-BDNF cargoes are actively transported along the length of the MTs by kinesin motors and are unloaded from the motors at the MT end junctions from where they diffuse into the inter-tubular space. After traversing each stage of MTs, the DCV-BDNF cargoes have been assumed to accumulate in the inter-MT space where an optimization formulation aims to minimize the average clearance time taken by the DCV-BDNF molecules for loading onto the next stage of tubules ([Figure 4](#f4-ijn-13-3105){ref-type="fig"}).

Assumptions made to model the transport of DCV-BDNF by kinesin molecules along axonal MTs are as follows: Kinesin motors move in a single file along a MT protofilament.At the minus end of the MT, the DCV-BDNF cargos are loaded onto new kinesin motors.At the plus end of the MT, the DCV-BDNF cargo detaches from the motor and diffuses in the area of the inter-MT space, that is, the MT end junctions of all MTs in that region.The arrival of cargoes at the plus or minus end of MT domains constitutes memoryless processes.

Based on these assumptions, the loading and unloading of DCV-BDNF molecules at the ends of the MTs are mod-eled using an M/M/1 queuing system where the system is characterized by single service and single arrivals.

One of the major mechanisms by which Ca^2+^ ions disrupt axonal transport of proteins is by interfering with the kinesin--cargo binding process.[@b4-ijn-13-3105] To incorporate this effect, it is assumed that Ca^2+^ ion concentration affects the loading and unloading of DCV-BDNF molecules in the queue. The average time (*t*) taken by DCV-BDNF molecules to move across an MT segment is given by $t = \frac{l}{v}$ where *l* is the length *υ* of the MT and *υ* is the average anterograde velocity of the kinesin motors carrying cargo (DCV-BDNF molecules). The effective service rate (*µ*) of the cargoes in the M/M/1 queue is defined as $$\mu = \mu_{0} - K$$where $\mu_{0} = \frac{l}{t}$ is the rate at which the cargoes traverse the MT segment and arrive at the plus end and $K = \frac{k^{\prime}Q}{4\pi Dt^{\prime}r^{\prime}}$ using [Equation (3)](#fd3-ijn-13-3105){ref-type="disp-formula"}, where *k′* is a proportionality constant.

In the M/M/1 queuing system, the probability of having *k* DCV-BDNF in the system is given by $$p_{ij}^{k} = (1 - \rho_{ij})\rho_{ij}^{k}$$where *ρ~ij~* is the utilization factor of the queue in the *i*th MT of the *j*th stage ([Figure 4](#f4-ijn-13-3105){ref-type="fig"}). Therefore, the average number of DCV-BDNF molecules in the *i*th MT of the *j*th stage is given by $$\overline{M_{IJ}} = \frac{\rho_{ij}}{1 - \rho_{ij}}$$

From Little's law, the average system delay (sum of average service time and average waiting time) in the *i*th MT of the *j*th stage can be given by $$T_{ij} = \frac{1/\mu_{ij}}{1 - \rho_{ij}}$$

For a model having m number of equilength parallel MT tracks and *n* such stages of MTs, the total system time for all queues is given by $$T = \frac{1}{m}{\sum_{i = 1}^{m}{\sum_{j = 1}^{n}T_{ij}}}$$

Thus, for all interconnected segments of the multisegmented axonal MT track, the same regional model and sequence of transport mechanisms are followed periodically. Thus, the number of cargoes accumulating at the inter-tubular space between the *j*th and (*j*+1)th stage of MTs is equal to $$M_{\textit{total\_j}} = {\sum_{i = 1}^{m}{\overline{M_{IJ}}\quad\forall j \in \lbrack 1,n\rbrack}}$$

The typical diameter of an axonal MT is 25 nm and the inter-MT gap is modeled as much smaller (order of nano-meter) than the MT length (order of micrometer).[@b29-ijn-13-3105] Taking the value of diffusion coefficient and time lapse of diffusion within a considerable range and the distances between parallel MTs in the range of a few nanometers, a loss of about 3%--5% is obtained in the inter-tubular regions.[@b39-ijn-13-3105]

Theoretically, the M/M/1 queuing system[@b40-ijn-13-3105] consists of an infinite "buffer capacity" which is impractical to test in simulation and in a real-life environment. We consider a finite "buffer capacity" to make the percentage of BDNF unrealized less than 4% when traversing the region between two MT segments.

### Problem formulation for optimization at the inter-MT gap junctions

Assuming that the DCV-BDNF cargos accumulating at the inter-MT gap junctions have access to all the MTs (represented as "gates") of the next stage, the DCV-BDNF cargos get selectively loaded onto the MTs of the next stage. The access to MT gates can be qualified and quantified using two parameters, namely 1) the total loading capacity of each MT and 2) clearance rate. Capacity of a gate (MT) is defined as the maximum number of DCV-BDNF molecules it can load and is given by the product of the capacity of each DCV and the number of DCV getting loaded, while the clearance rate is the number of molecules cleared through a gate per unit of time. The model design is proposed in a way that the DCV-BDNF cargoes arriving at the front end of each stage get selectively loaded onto the MTs of the next stage such that the time taken to clear the cargos through the gates is minimized. The aim of the optimization problem is to reduce the transportation delays that are not caused by AβO-induced calcium elevation mechanisms. That is, the optimization has been assumed to be a part of the efficient DCV-BDNF transport mechanism existing in normal cells.

To transfer *Mtotal* number of DCV-BDNF molecules through the gates, the total clearance time *G~j~* at the *j*th stage can be calculated using the following equation: $$G_{j} = \frac{M_{\textit{total\_j}}}{\sum_{i = 1}^{m}{r_{ij}x_{ij}}}\forall j \in \lbrack 1,n\rbrack$$

The notations used in the expression are defined in [Table 3](#t3-ijn-13-3105){ref-type="table"}. Practically, all biological systems are nonlinear in nature. To incorporate this nonlinear behavior and fit the optimization problem into a convex framework, modifications are made to the above equation by introducing a network parameter, that is, neuronal cell complexity parameter *α*. If we consider *α*=2 in mathematical analysis and simulation, the function *G* represents a second-degree nonlinear system which is partially differentiable with respect to *x~ij~*. Therefore, the modified expression *f* of the total clearance time is given as $$f = G_{j}^{- \alpha} = \frac{M_{total_{- j}}~^{- \alpha}}{\left\lbrack {\sum_{i = 1}^{m}{r_{ij}x_{ij}}} \right\rbrack^{- \alpha}}\forall j \in \lbrack 1,n\rbrack$$

Thus, the problem can be restated as follows: Minimize: $$f = \frac{M_{total\text{\_}j}^{- \alpha}}{{\lbrack\sum\limits_{i = 1}^{m}r_{ij}x_{ij}\rbrack}^{- \alpha}}\forall j \in \lbrack 1,n\rbrack$$Subject to: $$\frac{r_{ij}x_{ij}}{M_{\textit{total\_j}}} \leq \frac{C_{ij}}{\sum_{i = 1}^{m}c_{ij}}\forall j \in \lbrack 1,n\rbrack$$ $${\sum_{i = 1}^{m}{c_{ij}x_{ij} = M_{\textit{total\_j}}}}\forall j \in \lbrack 1 - n\rbrack$$ $$x_{ij} \leq 0\ \forall i \in \lbrack 1,m\rbrack,j \in \lbrack 1,n\rbrack$$

[Equation (10a)](#fd13-ijn-13-3105){ref-type="disp-formula"}: At any junction the fraction of total DCV-BDNF molecules that can be cleared by the *i*th gate at any given time must be less than or equal to the relative capacity of DCV in that gate, that is, $$\frac{r_{ij}x_{ij}}{M_{\textit{total\_j}}} \leq \frac{c_{ij}}{\sum_{i = 1}^{m}c_{ij}}\ \forall j \in \lbrack 1,n\rbrack$$

[Equation (10b)](#fd14-ijn-13-3105){ref-type="disp-formula"}: The total number of DCV-BDNF molecules cleared by the MT gates must be equal to the number of DCV-BDNF molecules accumulating in the gap junction. $$\sum_{i = 1}^{m}{c_{ij}x_{ij} = M_{\textit{total\_j}}\ \forall j \in \lbrack 1,n\rbrack}$$

[Equation (10c)](#fd15-ijn-13-3105){ref-type="disp-formula"}: As *x~ij~* is the number of DCV-BDNF molecules loaded in the *i*th MT gate, it has a non-negative value, that is, $$x_{ij} \geq 0\ \forall i \in \lbrack 1,m\rbrack,j \in \lbrack 1,n\rbrack$$

### Solution scheme

The optimization problem had been solved using Lagrangian relaxation and subgradient heuristic.[@b41-ijn-13-3105] This optimization scheme was chosen since it is one of the best methods available for finding the solution of any nonlinear problem. In this method, we relax the set of constraints using Lagrangian relaxation and solve the relaxed form of problem using subgradient heuristic. The possibility of solving the problem by linear programming by piecewise linearization of the problem is not considered. The primary reason is that such relaxed problems are very large and solving them requires considerable computational effort and would have generated fractional solutions. The subgradient heuristic is discussed in Supplementary Material (section "Lagrangian relaxation subgradient optimization algorithm"). Through this heuristic, we obtain a tight lower bound on minimal expected traversal time of DCV-BDNF molecules through neurons as well as a set of feasible solutions for the problem.

Metrics
=======

In this section, we define metrics to analyze the system's performance and discuss their impact upon the system. The metrics have been tabulated in [Table 4](#t4-ijn-13-3105){ref-type="table"}.

Unrealized DCV-BDNF percentage (P~b~)
-------------------------------------

This is defined as the percentage of DCV-BDNF molecules lost during neuronal transport. For normal cell conditions, this leakage should be very nominal, but for a diseased cell this may be very high. BDNF leakage consists of BDNF molecules lost during the transport due to finite buffer capacity at MT minus-end queuing regions and due to effects of calcium dysregulation. The following expression gives the mathematical formulation: $$P_{b}(\text{in}\%) = \frac{\left( \text{Total~no~of~DCV} \right) - \left( \text{BDNF~molecules~lost~during~transport} \right)}{\text{Total~no~of~DCV} - \text{BDNF~molecules~transmitted}} \times 100$$

Message deliverability (MD) measures whether a BDNF molecule survives long enough to accumulate at the intended receiver (gate). Deliverability is defined as the ability of the transmitter to increase the amount of BDNF molecules received at the receivers (successive MT stages). This is measured as a probability that the BDNF can be delivered to the gates before it leaks during transport.[@b6-ijn-13-3105] $$MD(\text{in}\ \%) = 100 - P_{b}(\text{in}\ \%)$$

Average traversal time per BDNF molecule (*T~trav~*)
----------------------------------------------------

This metric is eventually a measure of latency or response time of a system. In the context of our model, this metric is defined as the average time one message carrier takes to traverse the compartment of a neuron (ie, the time gap between the two events, namely the arrival of DCV-BDNF molecules inside the cell from different sources and reception of those molecules by the MT gates). The average traversal time has two components as follows. The average time taken due to diffusion (*T~diff~*)This delay (time taken) is a function of the distance between the point of consideration and generation and the diffusion coefficient and is given by: $$T_{diff} = \frac{x^{2} + y^{2}}{2D}$$For diffusion delay, we only consider diffusion from the source to the minus end of first MT. The inter-MT diffusion time is negligible for very short distances. Here, (*x*, *y*) is the position of consideration and *D* is the diffusion coefficient of DCV-BDNF molecules at the minus end point of the MT segments of the first stage. In our model, this component yields a constant value as the MT segments have been assumed to remain static.Average clearance time of BDNF through MT gates (*T~gate~*)The gate selection should occur in such a manner as to minimize this component, already discussed in the problem the "Formulation for optimization at the inter-MT gap junctions" section. $$T_{gate} = \frac{\text{Optimised~DCV} - \text{BDNF~clearance~delay~at~the~MT~gates}}{\text{No~of~ions~reaching~in~front~of~MT~gate~receiver~assembly}}$$

This is the variable delay component depending on the distribution of DCV-BDNF on the MT gates.

Finally, the total traversal time per DCV-BDNF, $$T_{trav} = T_{diff} + T_{gate}$$

Diffusive flux (*J~diff~*)
--------------------------

Diffusive flux is the rate of flow of BDNF molecules through the cross-sectional juncture area of each MT due to a concentration difference.[@b6-ijn-13-3105]

Diffusion equations along x and y directions are given by: $$c^{\prime}(x^{\prime},t^{\prime}) = \frac{c_{0}}{\sqrt{4\pi Dt^{\prime}}}e^{- \frac{{x^{\prime}}^{2}}{4dt^{\prime}}}$$ $$c^{\prime}(y^{\prime},t^{\prime}) = \frac{c_{0}}{\sqrt{4\pi Dt^{\prime}}}e^{- \frac{{y^{\prime}}^{2}}{4Dt^{\prime}}}$$where *c*′(*x*′, *t*′) and *c*′(*y*′, *t*′) are the concentrations of BDNF molecules for one-dimensional diffusion along *x*′ and *y*′ directions, respectively, *c*~0~′ is the initial concentration of BDNF molecules, and *D* is the diffusion coefficient of BDNF molecules.

Since this metric is a scalar quantity, the diffusive flux at any point located at (x′, y′) is the sum of flux at that point along x axis and along y axis. The expression of diffusive flux is given by $$J_{diff} = - D\left( {\frac{\partial c^{\prime}}{\partial x^{\prime}} + \frac{\partial c^{\prime}}{\partial y^{\prime}}} \right)$$

Active network programmability (ANP)
------------------------------------

DCV-BDNF molecules change the media component as they transport information from the soma cytosol to MT. ANP is defined as the change in BDNF "flux" due to these two media component changes.[@b6-ijn-13-3105] Flux in cytosol is diffusive in nature (*J~diff~*), while flux on the MT (*J~MT~*) is dependent upon the velocity of the vesicles, and the length and diameter of MT. If DCV-BDNF molecules do not change the underlying media component, then the value of this metric is zero. [Equation (19)](#fd27-ijn-13-3105){ref-type="disp-formula"} gives the mathematical expression of ANP of BDNF molecules for neuronal transport. $$ANP = J_{diff} - J_{MT}$$where *J~diff~* is already discussed as the previous metric and *J~MT~* can be calculated as follows. $$\begin{array}{l}
{J_{MT} = \frac{\text{Rate~of~transport~of~DCV} - \text{BDNF~molecules~on~cargoes}}{\text{MT~cross} - \text{Sectional~area}}} \\
~ \\
\end{array}$$and $$\text{Rate~of~transport~of~BDNF~molecules~on~cargoes} = \frac{v}{l} \times \text{cargo~capacity}$$ $$\text{MT~cross} - \text{Sectional~area} = \pi \times \frac{Dim^{2}}{4}$$where $$\begin{array}{l}
{\text{Dim} = \text{MT~diameter}} \\
{l = \text{MT~length}} \\
{v = \text{average~velocity~of~DCV}–\text{BDNF}} \\
\end{array}$$

Results of simulation
=====================

The simulation environment for the neuronal system has been defined with proper parameter values and necessary assumptions discussed in the "Methods" section. The performance of our solution schemes is tested in a simulation environment built in C++. The code and documentation developed for our simulation environment are available in the public website Github as detailed and referenced in the "Discussion and conclusion" section.

The data set and the range of gate parameters used for the simulation are given in [Tables 5](#t5-ijn-13-3105){ref-type="table"} and [6](#t6-ijn-13-3105){ref-type="table"}. In this section, we show a set of results corresponding the metrics with the parameters given in [Tables 3](#t3-ijn-13-3105){ref-type="table"} and [4](#t4-ijn-13-3105){ref-type="table"}.[@b4-ijn-13-3105],[@b29-ijn-13-3105],[@b31-ijn-13-3105] [Table 7](#t7-ijn-13-3105){ref-type="table"} shows the complete system performance using our solution schemes while [Figures 5](#f5-ijn-13-3105){ref-type="fig"} and [6A--E](#f6-ijn-13-3105){ref-type="fig"} graphically plot the results.

In [Table 7](#t7-ijn-13-3105){ref-type="table"}, "tot_gen" denotes the total number of DCV-BDNF molecules generated by the transmitter and "tot_arv" is the total number of DCV-BDNF molecules reaching the vicinity of the MT gates. For each pair of values (ie, for tot_gen and tot_arv), the values of *c~ij~* and *r~ij~* are taken in the range defined in [Table 6](#t6-ijn-13-3105){ref-type="table"} and optimized number of DCV-BDNF molecules (*x~ij~*) loaded in the *i*th MT gate of the *j*th stage where *i*∈\[1, *m*\] and *j*∈\[1, *n*\] is found. With the increase of the number of segments in each axonal MT, the number of constraints in the optimization problem increases ([Equations 10a](#fd13-ijn-13-3105){ref-type="disp-formula"}, [10b](#fd14-ijn-13-3105){ref-type="disp-formula"}, and [10c](#fd15-ijn-13-3105){ref-type="disp-formula"}). Consequently, the Lagrange multipliers become higher in number and the dimension of the solution space increases which, in turn, makes the computation complex for large number of MT segments. The number of MT gates included is restricted to six in this simulation since the issues of scalability and complexity of optimization come into effect. In [Table 7](#t7-ijn-13-3105){ref-type="table"}, we run the simulation corresponding to five and six MT gates. The simulation can be extended for higher number of MT gates using higher-end computing platform.

Effect of varying calcium levels due to interaction of AβOs with membrane calcium channels
------------------------------------------------------------------------------------------

[Table 8](#t8-ijn-13-3105){ref-type="table"} describes the effect of varying calcium levels on the number of DCV-BDNF molecules reaching the MT ends, that is, variation of BDNF unrealized percentage (*P~b~*) with the concentration of Ca^2+^ ions. Our results infer that the leakage of DCV-BDNF molecules in the queues increases with increase in cytosolic calcium concentration, which decreases the number of DCV-BDNF molecules reaching the front end of gates. Our result is in accord with biological phenomenon of effect of Ca^2+^ concentration on BDNF molecules in axon.[@b4-ijn-13-3105]

It is known that Ca^2+^ influx through the channels increases in the presence of AβO. This perturbation increases the cytosolic Ca^2+^ concentration in the neuron, which ultimately results in disruption of FAT. In a study by Gan and Silverman,[@b4-ijn-13-3105] it was observed that after 5 hours of AβO presence, there was a significant increase in fluorescence resonance energy transfer (FRET) between the M13-cp Venus acceptor and the calmodulin--cyan fluorescent protein (CFP) donor in the neuron, as compared to normal condition. FRET ratios had doubled after 13 hours of AβO presence ([Figure 2](#f2-ijn-13-3105){ref-type="fig"} of Gan and Silverman's article[@b4-ijn-13-3105]). In the study by Miyawaki et al,[@b42-ijn-13-3105] it was shown that the emission ratio for different acceptor--donor pairs doubles as the calcium concentration increases by 10^3^ M. Using these results, we have mapped the effect of presence of AβO on the Ca^2+^ generation rates of the dendritic-soma channels. The Ca^2+^generation rate of the channels has been assumed to increase fourfold after 13--18 hours with a projected increase of fivefold after 18 hours when AβO is present. [Table 9](#t9-ijn-13-3105){ref-type="table"} shows the modified generation rate for each receptor in the presence of AβO.

From [Figure 6E](#f6-ijn-13-3105){ref-type="fig"}, we observe that when the concentration of Ca^2+^ is nominal, unrealized BDNF percentage is very low, representing a healthy condition of cells. If we increase Ca^2+^ concentration over normal levels, the concentration of unrealized BDNF molecules increases gradually at lower Ca^2+^ levels but exhibits a steeper slope after a critical Ca^2+^ concentration.

Effect of calcium influx through AβO pores
------------------------------------------

Aβ has the ability to form aggregates of calcium-permeable pores that can vary in size and exhibit multiple conduction states.[@b20-ijn-13-3105] [Table 10](#t10-ijn-13-3105){ref-type="table"} simulates the effect of calcium influx through oligomeric Aβ1-42 pores/channels having two different conductance values.[@b16-ijn-13-3105]

A variation in the number of oligomeric Aβ1-42 pores/channels from 100 to 10,000 resulted in a very small change in the percentage of unrealized BDNF molecules. Moreover, a larger number of pores (or larger pore size as in some mutant forms of AβOs) are required to produce disruptive effects of similar magnitude as seen with other calcium channels analyzed here ([Figure 5](#f5-ijn-13-3105){ref-type="fig"}). This result is consistent with a model in which oligomeric Aβ1-42 pores/channels contribute to chronic long-term outcomes and exacerbate other Ca^2+^ channel dysregulation mechanisms rather than being responsible alone for acute changes leading to neurodegenerative effects such as changes in DCV-BDNF transport. We only evaluated DCV-BDNF transport, but it is expected that the disruption of Ca^2+^ homeostasis over several years leads to several target effects before evoking an acute neurodegenerative response.[@b18-ijn-13-3105]

On/off signaling of calcium channels
------------------------------------

The ON-OFF signaling of calcium channels is also simulated in our model. It involves simulation carried under some constrained conditions, which, in this case, implies blocking of one or more dendritic-soma calcium channels. Such findings can help direct the value of targeting specific receptors by using appropriate blockers in targeted drug delivery applications.

[Tables 11](#t11-ijn-13-3105){ref-type="table"} and [12](#t12-ijn-13-3105){ref-type="table"} tabulate the response of the model for different combinations of the receptor states and different levels of Ca^2+^. A comparison is made between the percentage of unrealized BDNF in normal conditions and in the presence of AβO. Five different combinations of receptors' state are modeled where each receptor can be in either of the two states, ON or OFF. The simulation is run for several times, varying the number of DCV-BDNF molecules generated in each case, and the corresponding results are noted. By varying the number of DCV-BDNF molecules generated in the range from 299,000 to 330,000, the behavior of the model is observed. It is observed that internal stores of Ca^2+^ such as the RyR channels on the endoplasmic reticulum (ER) play a significant role in increasing the percentage of unrealized BDNF molecules.

[Figure 5](#f5-ijn-13-3105){ref-type="fig"} shows the BDNF unrealized percentage for each of the ON/OFF cases under the normal and AβO treated cases based on the results tabulated in [Tables 11](#t11-ijn-13-3105){ref-type="table"} and [12](#t12-ijn-13-3105){ref-type="table"}.

Optimal buffer capacity of MTs
------------------------------

Biologically, the buffer capacity can be interpreted as the number of BDNF molecules that can be stored near the MT ends. From [Figure 6A](#f6-ijn-13-3105){ref-type="fig"}, we observe that the variation of the percentage of unrealized DCV-BDNF molecules decreases almost linearly with increase in buffer capacity. For a normal neuron, the leakage percentage must be low. From the graph, it is observed that for a buffer capacity greater than 11,000 molecules, leakage becomes asymptotically constant. Hence, "optimal" buffer capacity is taken in the range of 11,000--12,000 molecules in our simulation.

In [Figure 6C](#f6-ijn-13-3105){ref-type="fig"}, the variation of DCV-BDNF deliverability with buffer capacity for different calcium levels is shown. It is observed that for a buffer capacity in the range of 11,000--12,000 molecules, the number of BDNF molecules received at the MT gates is maximum. The message deliverability reaches a saturation level upon further increase of buffer capacity.

Optimal loading rate of DCV-BDNF on MTs
---------------------------------------

In [Figure 6B](#f6-ijn-13-3105){ref-type="fig"}, the variation of the BDNF leakage versus loading rate for different calcium levels is shown, keeping the buffer capacity at 11,000 ions (optimal) and average generation (arrival) rate as 20 molecules/ns. From this figure, we observe that the nature of the curve is convex and that the leakage of BDNF molecules is minimum when the average loading rate of BDNF, that is, the rate at which the BDNF molecules are transferred in the cargoes, is kept at around thrice the average rate at which the BDNF molecules are transmitted. It can also be observed that for a fixed loading rate, the unrealized BDNF molecules increase with increase in calcium levels in neuron.

In [Figure 6D](#f6-ijn-13-3105){ref-type="fig"}, the variation of message deliverability with loading rate for different calcium levels is shown, keeping the buffer capacity at optimal value (11,000--12,000 molecules) and average BDNF incoming rate from multiple sources as 20 molecules/ns. From this plot, we once again infer that the average loading rate of DCV-BDNF molecules in the cargo must be around thrice the average rate of BDNF transmission to ensure a high percentage of message deliverability.

Limitations of the study
========================

To better understand normal development, aging, and complex neurodegenerative disease states, new models are needed at the level of a single neuron that enable detailed molecular subcellular events to be simulated in end-to-end communication scenarios in order to reveal molecular events that correlate with multilevel CNS disease outcomes. Modeling of dysregulation of calcium in neurodegenerative tauopathies and other axonopathies is expected to bring new insights into disease mechanisms of shared or distinct pathologies of neurodegeneration from initiation to progression that will be expandable to the clinic. Such models could then be useful to distinguish AD patients versus age-related no AD patients (controls), as well as provide new information on AD disease progression helping to identify and evaluate linked biomarkers for diagnostic and prognostic abilities. The current model applies concepts generated in the recent IEEE Standard Association 1906.1-2015 Recommended Practice for Nanoscale and Molecular Communication Framework in a layered architecture framework to analyze end-to-end events linking AβO dysregulation of calcium ion influx, elevated intracellular calcium levels, and disruption of axonal transport of DCV-BDNF by kinesin on bundled discontinuous axonal MT tracks. Levels of AβOs, oligomer sequence, intracellular calcium levels, and BDNF levels together may be more prognostic as clinical indicators of AD, whereas BDNF alone has resulted in mixed findings, although more recent studies correlate reduced levels with disease progression.[@b43-ijn-13-3105]--[@b45-ijn-13-3105] Here, we summarize limitations of the current study specifically as well as needed advances. Need for additional experimental details on axonal MT cytoskeleton organization and mechanisms. MT-based mechanisms are generally conserved between dividing cells and neurons but with additional functional specialization in neurons. Informed structural analysis often requires high-resolution TEM[@b46-ijn-13-3105] or for live cells high-throughput analysis of axonal functions by a combination of microfluidic devices along with super-resolution time-lapse microscopy.[@b47-ijn-13-3105] In development of the current model, parameters were kept restricted to limit complexity but can be adjusted in future iterations to include additional layers of detail for alternate cargos, vesicle size, loading capacity, kinesin processivity, capacity of MT tracks affected by cross-linking proteins or minus- and plus-end complexes, as well as ability of cargo to move in between adjacent MTs to avoid end complexes. This will depend on questions asked and ability to get experimental data or to extrapolate data from other models.[@b23-ijn-13-3105],[@b48-ijn-13-3105]Interaction of MT and actin axonal cytoskeletons. The current model does not evaluate transfer of BDNF vesicles to actin filaments and delivery to the plasma membrane.[@b49-ijn-13-3105] Since this is important for synaptic release of BDNF, future models would benefit with this extension of the end-to-end communication pathway.Need for additional detailed membrane channel data at the molecular level. Single-molecule analysis of channels is possible although not widely applied with analysis of ion influx rates. No studies currently compare directly the calcium channel regulation by Aβ with Aβ pore formation, although both have now been separately analyzed. A challenge to such comparisons is to precisely calculate the number of calcium channels and Aβ pores (and monitor internal pore size) present along with kinetics of the AβO interactions and consistency of ionic influx.RyR channel data and AβO interactions. The ability of AβO to regulate RyR channels on the ER can occur by direct interactions or indirectly through the activation of G-protein-coupled receptors.[@b50-ijn-13-3105] It is reasonable to expect that oligomeric Aβ pore size will directly impact monomeric and oligomeric Aβ entry into cells. Here we evaluated oligomeric Aβ1-42 pores of 24 nm external diameter and 2--6 nm internal pore size that could potentially provide access to AβOs and monomers (1×3.5 nm)[@b16-ijn-13-3105],[@b20-ijn-13-3105] into the cytoplasm and gain access to RyR channels whereas smaller pores would not.Need for human disease models of neurodegeneration. Human-induced pluripotent stem cell biology and clustered regulatory interspaced short palindromic repeats technologies are being applied to develop isogeneic and epigenetically near-identical control and disease neuron cell type-specific models that will aid in iterative computational-experimental testing.Need to develop biomarkers to quantify Aβ-regulated calcium channels versus membrane Aβ pores. For in vivo analysis of patients, a noninvasive challenge requires developing traceable molecules that might be able to distinguish calcium channels versus Aβ pore ratios if future experimentation and models warrant ratios in disease scenarios.Need to develop intracellular biomarkers to track end-to-end events. In vitro models can implicate links in molecular events leading to neurodegeneration that may impact clinical studies. An end-to-end scenario has the advantage of identifying communication-linked biomarkers that may be more disease relevant in combination than when evaluated individually.

Discussion and conclusion
=========================

Neurons communicate information through chemical signaling, which traverses not only extracellular space but also multiple intracellular specialized compartments that utilize distinct molecular mechanisms. Intracellular disruption of axonal transport by changes to MT dynamics or organization within the axon, or by altered action of MT motor proteins with cargo on MTs (such as kinesins and DCV-BDNF modeled here) as well as altered homeostasis of key regulators such as calcium are all believed to contribute to progression of neurodegenerative disorders such as Alzheimer's disease. New mathematical models capable of looking at nanoscale communication events with greater detail and which can link multiple processes to specific outcomes will better reflect the intracellular biological complexity and improve overall neurodegenerative disease modeling. In the current study, we make use of a new mathematical modeling platform designed to investigate communication events at the nano-to microscale, referred to as the Nano, Electrical, Molecular (NEMo) communication, to link for the first time multiple events in a nanocommunication network that includes calcium influx through multiple membrane-bound channels and AβO pores/channels and the elevated calcium concentration effects on DCV-BDNF loading and transport by kinesins, including the complex axonal architecture of bundled and gapped discontinuous MT tracks within the axon. As a communication network, the model provides spatiotemporal information and makes predictions on efficiencies in various steps of intracellular neuronal signaling.

We have defined the underlying communication system in neuronal cells regarding message, message carrier, receiver, transmitter, and medium, concepts developed in the IEEE standard model NEMo communication platform.[@b6-ijn-13-3105],[@b54-ijn-13-3105] The NEMo platform is ideal for modeling intracellular nano-molecular events and has not previously been applied to neurons. It uses a physical layer protocol framework to map communication systems. In our model, we proposed that the Ca^2+^ ion concentration in axons is affected primarily by cytoplasmic soma delivery following membrane channel influx. Calcium ion movement through the cytosol of the soma is modeled by passive diffusion. In addition, diffusion parameters are considered at the discontinuous gaps for connecting MT end junctions in the axon. To quantify entry of DCV-BDNF molecules into the axon, we applied a memoryless distributed queuing network where the corresponding arrival and service rates are practically associated with the parameters of neuron components. We have formulated a convex nonlinear optimization problem to determine the optimal number of channels required to minimize the transportation time of BDNF molecules. We determined Ca^2+^ ion concentration distributions within the soma-axonal MT cargo loading region on polarized MTs and in relation to a bundled MT structure and axonal kinesin-cargo transport capabilities. We defined a set of metrics through which we could show performance of the model and analyzed these metrics to draw inferences on axonal transport of DCV-BDNF cargo. The ability to link the end-to-end events resulting from Ca^2+^ influx to a specific outcome of DCV-BDNF transport provides information that will direct future experimentation in regard to the "calcium hypothesis of AD" while also allowing further downstream events that are MT based to be analyzed in future iterations. During our analysis that included published experimental results,[@b4-ijn-13-3105] we used this platform to sequentially simulate multiple events in the transport of Ca^2+^ ions including influx at the cell body/soma through Ca^2+^ channels or Aβ1-42 pores/channels, diffusion of the Ca^2+^ ions toward the proximal MT segments in the AIS region, DCV--BDNF--kinesin interactions and MT loading, MT transport along polarized MTs from the minus-end to the plus-end region, and unloading/reloading at discontinuous MT end junctions. Within the axon, all the necessary queuing operations are simulated dynamically in the presence of all events for MT segments as a bundle in tandem that contribute to the initial BDNF-vesicle transport events proximal to the soma and are needed to occur successfully before eventually reaching the vicinity of the distal growth cone/future forming synapses.

No current model exists that considers the entire structural, morphological, dynamic, or temporal complexity of intracellular communication within neurons, which is a tremendous challenge. Here too we restrict our model, focusing on polarized MTs in the region of the neuronal AIS for loading and one cargo type and kinesin transporter. We evaluate bundled MTs and gapped regions of discontinuous MTs within the axon; however, more complex axonal features can be added in future iterations to consider gaps in myelination of axons providing distal ionic regulation at specialized nodes of Ranvier, distribution of axonal mitochondria or ER and MT organization changes from branching, axonal growth or retraction, and synaptogenesis. In regard to calcium signaling homeostasis or dysregulation along the axon length, the ability of internal calcium stores to contribute to calcium ion regulation (within soma and along axon), as well as the complex balance of chemical and ionic signaling at nodes of Ranvier[@b55-ijn-13-3105],[@b56-ijn-13-3105] can be added to expand the depth of our model. In addition, the number of MTs within an axon, axon length, and MT polarity are not static and can vary during developmental maturation, dynamic retraction, and disease.[@b57-ijn-13-3105],[@b58-ijn-13-3105] Also of high importance is the role of additional MAPs that are motile connectors that allow sliding or immotile spacers such as MAP-tau that can stabilize dynamics as well as affect viscoelasticity in axonal stretching[@b24-ijn-13-3105],[@b25-ijn-13-3105] and have been evaluated in torsional models.[@b26-ijn-13-3105] As well, different dendrite and axonal branching morphologies exist for different neuronal types allowing for different calcium signaling configurations and requiring integration of morphological simulations.[@b59-ijn-13-3105] The computational complexity of the neuron is staggering and the detailed biological data are often not available or limited in ability to describe and model all physiological or signaling events. Yet models critically help to identify gaps in experimentation and enable rapid testing of new theories to reiteratively guide future experimentation to fill these knowledge gaps.

In our approach, because the calcium-linked events involve conveying a message from a transmitting party to a receiving party, we have chosen to define these events as a communication network and model it in accordance with the definitions given in the IEEE Recommended Practice for Nanoscale and Molecular Communication Framework. The IEEE p1906.1-2015 standard applies Shannon's rules of communication theory for systems with nanoscale components even if they operate multiscale from nanoscale over larger scales.[@b6-ijn-13-3105],[@b54-ijn-13-3105] The NEMo software is designed to apply the IEEE standard framework. Some of the current limitations of the model relate to the need for more detailed information and as such may help to drive this type of experimental discovery. The model consists of two types of motion, passive and active and means that the saltatory motion of kinesin motors cannot be described by a fluid flow model, hence the idea of queuing theory was chosen. We define kinesin motors as "packets" carrying vesicles in an abstract sense and considered defining headers based on the structural information of vesicles. However, more biological information is needed to consider precise analogies. The availability to map biological systems to communication systems is expected to be beneficial in eventually linking these nanoscale events to micro- and macroscale neural signaling in the brain.

Our propagation model provides an end-to-end communication scenario, membrane channels to axonal MT-based transport, that allows us to evaluate channel input to calcium dysregulation and the queuing and clearance parameters of DCV-BDNF molecules transported by kinesin along axonal MTs.[@b73-ijn-13-3105] By modeling the selective blocking of different calcium channels as well as evaluating oligomeric Aβ1-42 pores/channels, our model indicates that the internal source of calcium is the major calcium contributor during dysregulation, followed by calcium channels and then oligomeric Aβ1-42 pores/channels. As well, our simulation indicates that there exists an optimal capacity and loading rate of DCV-BDNF onto MTs. In our queuing model, we evaluate calcium ion concentration affecting the service process of motors. That is, we show mathematically how the effect of calcium ions on the binding of motors to cargoes creates substantial differences in the transported flux. The cargo-motor binding mechanism can serve as the primary method for calcium ions to impact BDNF transport in diseased cells. Identification of the primary impact sites of calcium dysregulation in the neuron and the manner in which calcium ions (or complexes generated by downstream pathways) further dysregulate communication events can pave future paths for introducing technologies to internally monitor the calcium levels at multiple key functional sites. Our model is a step in this direction. Biological validation through extensive experimentation coupled with relevant computational models that can process the additional details are required to develop more accurate predictor models that will advance our understanding of neural development and neurodegeneration. For future researchers wanting to develop drugs to block AβO through identification of calcium action sites and mechanisms, this work stands as a novel approach to unify the domains of modeling and experimentation.

Supplementary materials
=======================

Knuth's algorithm
-----------------

[Table S1](#SD1-ijn-13-3105){ref-type="supplementary-material"} summarizes the notations used for the algorithm.

Algorithm:

Initialization: $$\left. E\leftarrow\exp( - \lambda^{\prime}),k\leftarrow 0\ \text{and}\ p\leftarrow 1 \right.$$do: $$\left. k\leftarrow k + 1 \right.$$

Generate uniform random number u in \[0, 1\] and

let p ← p × u

while p \> E

return k − 1

Lagrangian relaxation subgradient optimization algorithm
--------------------------------------------------------

[Table S2](#SD2-ijn-13-3105){ref-type="supplementary-material"} summarizes the notations used for optimization problem. Lagrangian relaxationGiven an objective function and a set of constraints, the Lagrangian relaxation is used to eliminate several constraints of the problem. In this technique, we multiply the constraints by several non-positive Lagrange multipliers, *ψ~ij~*, where *i*∈\[1, *m*\], and *j*∈\[1, *n*\], add them to the objective function to get Lagrangian relaxed form of the problem given by $$L(\psi) = \min\left\lbrack {\frac{M_{\textit{total\_j}}^{- \alpha}}{\left\lbrack {\sum_{i = 1}^{m}{r_{ij}x_{ij}}} \right\rbrack^{- \alpha}} + {\sum_{i = 1}^{m}\left\lbrack {\psi_{ij}\left( {1 - \frac{\sum_{i = 1}^{m}{r_{ij}x_{ij}}}{c_{ij}M_{\textit{total\_j}}}} \right)} \right\rbrack}} \right\rbrack$$Subject to $${\sum_{i = 1}^{m}{c_{ij}x_{ij} = M_{toatal\_ j}}}\quad\forall j \in \lbrack 1,n\rbrack$$and $$x_{ij} \geq 0\forall i \in \lbrack 1,m\rbrack\ and\ j \in \lbrack 1,m\rbrack$$The set of feasible solutions for the problem IP is indeed the subset of the set of feasible solutions for Lagrange relaxation of problem IP.[@b74-ijn-13-3105] Then positive values of *ψ* ensure that in any feasible solution for problem IP, the expression $\sum_{i = 1}^{m}\left\lbrack {\mathbf{\Psi}_{ij}\left( {1 - \frac{\sum_{i = 1}^{m}{r_{ij}x_{ij}}}{c_{ij}M_{total}}} \right)} \right\rbrack$ evaluated is non-positive, the value of the Lagrangian in [Equation (S1)](#fd34-ijn-13-3105){ref-type="disp-formula"} is never greater than the value of the objective function in problem IP. Thus, whenever the optimization problem IP has a feasible solution, *L*(*ψ*)≤*f*. For each value of multiplier, *L*(*ψ*) is the lower bound of *f*. The best possible bound for such a procedure is given by the vector of multipliers *ψ***^\*^** that satisfies *L*(*ψ***^\*^**) = max*ψ*≤0*L*(*ψ*).Subgradient heuristicVarious methods are present in literature to produce a vector of optimal Lagrange multipliers for combinatorial optimization problems. The subgradient heuristic is a method to heuristically solve a Lagrangian problem. It iteratively adjusts the Lagrangian multipliers to find values that produce the best or nearly the best lower or upper bound. This was the motivation for using this subgradient procedure.Let *x~i~*(*ψ*) be the optimal solution for a specific Lagrange vector *ψ*. A subgradient is a vector with coordinates, $$\left( {\Gamma_{i}(\mathbf{\Psi}) = \left( {1 - \frac{r_{i}x_{i}(\psi){\sum_{j = 1}^{n}c_{j}}}{c_{i}N_{total}}} \right)\forall i \in \lbrack 1,n\rbrack} \right)$$Let *ψ***^\*^** be the optimal Lagrange vectors for the problem. It is shown that when the multipliers are updated using the iterative formula, $$\psi_{ij}^{m^{\prime} + 1} = \mathbf{\Psi}_{ij}^{m^{\prime}} + t_{m^{\prime}}\Gamma_{ij}^{m^{\prime}}$$then $\mathbf{\Psi}_{ij}^{m^{\prime}}$ converges to *ψ***^\*^** if $t_{m^{\prime}}$ converges to 0 and $\sum t_{m^{\prime}}$ diverges. The value of $t_{m^{\prime}}$ can be updated by the following equation:[@b75-ijn-13-3105],[@b76-ijn-13-3105] $$t_{m^{\prime}} = \delta\frac{\overline{f} - L(\mathbf{\Psi}^{m^{\prime}})}{\left| \left| \Gamma^{m^{\prime}} \right| \right|^{2}}$$

It can be shown that if 0 \< *δ* ≤ 2 and $\overline{f} \leq L(\psi^{*})$ the sequence in [Equation (S2)](#fd37-ijn-13-3105){ref-type="disp-formula"} converges to *ψ*^\*^. With $\overline{f} \geq L(\psi^{*})$, $t_{m^{\prime}}$is computed iteratively.

The steps involved in subgradient heuristic are described in detail in a work by Gavish and Hantler.[@b77-ijn-13-3105]

###### 

Symbols used in Knuth's algorithm

  Sl no   Symbol   Meaning
  ------- -------- ----------------------------------------------------------------------------------------------------------------
  1       E        Floating point variable that stores the exponential inter-arrival time depending upon the generation rate (λ′)
  2       k        Counts the number of ions/molecules produced during the time E
  3       p        The incremental time value which increments in each loop execution until its value is less than E
  4       u        Random value between \[0, 1\] generated in each loop execution

###### 

Notations used in subgradient heuristic

  Sl no   Symbol             Meaning
  ------- ------------------ -------------------------------------------------------------------------------------------------
  1       **Ψ**              A vector of Lagrange multipliers
  2       **Ψ**^\*^          Optimal vector of Lagrange multipliers
  3       *f*                Objective function of the problem
  4       *L*(**Ψ**)         Lagrange relaxed form of objective function
  5       $\overline{f}$     An arbitrarily large value (used for initialization)
  6       *Γ~ij~*            Subgradient vector of the relaxed form of objective function, *i*∈\[1, *m*\] and *j*∈\[1, *n*\]
  7       *m*′               Loop iteration variable
  8       *δ*                Parameter for adjusting step size
  9       $t_{m^{\prime}}$   New step size at *m*th iteration

**Note:** Bold symbols denote vector quantities.
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![Axonal impacts of biological flow of information in a neuron.\
**Notes:** In the calcium hypothesis of neurodegeneration, amyloid beta oligomers (AβOs) alter the flow of calcium channels, resulting in elevated internal calcium with subsequent effects on kinesin loading and transport of DCV-BDNF cargo on axonal microtubules. The contributions of axonal endoplasmic reticulum and transported mitochondria to sink excess calcium or potential ionic changes in the regions of the nodes of Ranvier are not included in the current model in which excess calcium dominates outcomes.\
**Abbreviations:** DCV, dense core vesicle; BDNF, brain-derived neurotrophic factor; MT, microtubule; NR, Node of Ranvier.](ijn-13-3105Fig1){#f1-ijn-13-3105}

![Calcium is a key regulatory molecule for internal neuronal signaling.\
**Note:** Calcium internal cellular levels are increased through AβO-activated influx and moderated in part by internal stores.\
**Abbreviations:** VGCC, voltage-gated Ca^2+^ channel; NMDA, N-methyl-D-aspartate; AMPA, α-amino-3-hydroxy-5-methyl-isoxazolepropionic acid; ER, endoplastic reticulum; AβO, amyloid beta oligomer; RyR, ryanodine receptor; CICR, calcium induced calcium release; SERCA, sarco-endoplasmic reticulum calcium ATPase; IP~3~R, inositol 1,4,5-triphosphate receptor.](ijn-13-3105Fig2){#f2-ijn-13-3105}

![Schematic block diagram representing mapping of intracellular neuronal signaling to the IEEE standards association 1906.1 nanoscale and molecular communication framework.\
**Note:** The flow of information passes from transmitter througropagation medium to receiver and these steps are described in detail in the text.\
**Abbreviations:** VGCC, voltage-gated Ca^2+^ channel; NMDA, N-methyl-D-aspartate; AMPA, α-amino-3-hydroxy-5-methyl-isoxazolepropionic acid; ER, endoplastic reticulum; DCV, dense core vesicle; BDNF, brain-derived neurotrophic factor; MT, microtubule; CICR, calcium induced calcium release.](ijn-13-3105Fig3){#f3-ijn-13-3105}

![Parameters for modeling calcium-mediated DCV-BDNF transport by kinesins along axonal MTs and predictions.\
**Notes:** (**A**) Model of calcium-mediated BDNF transport on axonal MTs. The BDNF-DCV cargo (orange circle) binds to kinesin (blue square) for MT docking and transport. For simplicity, a loaded cargo is considered stable until MT ends where calcium concentration can again affect disruption or reassociation of BDNF-DCV cargo to MTs or MT binding by kinesin carrying cargo. The figure also indicates 1) BDNF-DCV binding to kinesin and 2) DCV-BDNF-kinesin-MT binding with cargo. In 3) and 4) MT end complexes at MT minus (-) or plus (+) ends including MAP or severing proteins can affect MT end dynamics or length and contribute to lost cargo. Points 3) and 4) are not modeled here but will be considered in future iterations. (**B**) Key predictions from simulation of calcium-regulated BDNF transport.\
**Abbreviations:** DCV, dense core vesicle; BDNF, brain-derived neurotrophic factor; MT, microtubule; MAP, MT-associated protein; FAT, fast axonal transport; AIS, axon initial segment; ER, endoplastic reticulum; RyR, ryanodine receptor.](ijn-13-3105Fig4){#f4-ijn-13-3105}

![Overall unrealized percentage of DCV-BDNF that is communicated under different calcium levels and conditions.\
**Notes:** (**A**). The five cases corresponding to the on and off rates by selectively blocking different calcium channels. These simulations are discussed in the text and [Tables 9](#t9-ijn-13-3105){ref-type="table"} and [10](#t10-ijn-13-3105){ref-type="table"}. (**B**). The formation of oligomeric Aβ pores/channels more moderately affects internal Ca^2+^ levels even at high number. Internal pore dimensions[@b16-ijn-13-3105],[@b20-ijn-13-3105] are discussed in the text along with the simulations and data in [Table 8](#t8-ijn-13-3105){ref-type="table"}.\
**Abbreviations:** DCV, dense core vesicle; BDNF, brain-derived neurotrophic factor; VGCC, voltage-gated Ca^2+^ channel; AMPA, α-amino-3-hydroxy-5-methyl-isoxazolepropionic acid; NMDA, N-methyl-D-aspartate; RyR, ryanodine receptor; AβO, amyloid beta oligomer.](ijn-13-3105Fig5){#f5-ijn-13-3105}

![Different metrics calculated from simulation of AβO regulation of membrane calcium channels and its effects on BDNF transport on axonal MTs.\
**Notes:** (**A**) Variation of unrealized DCV-BDNF percentage with buffer capacity for different calcium levels. (**B**) Variation of unrealized DCV-BDNF percentage with BDNF loading rate for different calcium levels. (**C**) Variation of message deliverability with buffer capacity. (**D**) Variation of message deliverability with BDNF loading rate for different calcium levels. (**E**) Variation of unrealized DCV-BDNF percentage with intracellular calcium concentration.\
**Abbreviations:** AβO, amyloid beta oligomer; DCV, dense core vesicle; BDNF, brain-derived neurotrophic factor; MT, microtubule.](ijn-13-3105Fig6){#f6-ijn-13-3105}

###### 

The current end-to-end communication model compared to existing discrete step biophysical models

  Reference                                 Component modeled                                       Model description
  ----------------------------------------- ------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Present work (this study)                 Transmitter, channel, and receiver (end-to-end model)   Our model is designed to be an apt manifestation of a biological system, the neuron, incorporating some of the complexities of neuronal axonal morphology versus a generic cell. We include multiple calcium sources in our transmitter parameters and utilize a propagation model comprising the receptors on plasma membrane channel, cytosol, and impact on axonal MT loading of DCV-BDNF molecules for transport. Moreover, we provide information on number of gates necessary for rapid clearance of BDNF molecules at the AIS using Lagrangian relaxation and subgradient heuristic as a predictor of maximal accelerated neurodegenerative events.
  Feinerman and Elisha[@b60-ijn-13-3105]    Channel                                                 A channel-oriented model in which the transmission of calcium ions through a predefined network/pathway (channel) was monitored.
  Amrita and Neeru[@b61-ijn-13-3105]        Transmitter                                             An intracellular mathematical model for calcium dynamics that considered a number of diffusion and chemical kinetics equations.
  Fogelson and Zucker[@b62-ijn-13-3105]     Transmitter and channel                                 A one-dimensional model of presynaptic calcium diffusion where the transmitter generated a spike, and the calcium behavior in the channel is subsequently monitored.
  Berridge[@b63-ijn-13-3105]                Transmitter                                             A number of intracellular and extracellular sources responsible for the influx of external calcium (VOC, NMDA, etc.) were modeled.
  Pierobon and Akyildiz[@b64-ijn-13-3105]   Receiver                                                Ligand binding-based receptors were modeled using stochastic computing. It is one of the very few papers where receiver is modeled.
  Nakano et al[@b65-ijn-13-3105]            Channel                                                 Simple network of nanomachines was described.
  Moore et al[@b66-ijn-13-3105]             Channel                                                 Molecular motor-based transport modeling was discussed but not specifically for neuron.
  Nitta et al[@b67-ijn-13-3105]             Channel                                                 A generic model in which transport was modeled as a network on chip.
  Pierobon and Akyildis[@b68-ijn-13-3105]   End-to-end                                              A generic biophysical model was proposed but was not considered for neuron cell.
  Kuran et al[@b69-ijn-13-3105]             Mainly channel                                          Although it was a diffusion-based generic model, modulation techniques of digital communication were widely used. An important work was from communication point of view.

**Abbreviations:** MT, microtubule; DCV, dense core vesicle; BDNF, brain-derived neurotrophic factor; AIS, axon initial segment; VOC, voltage operated channel; NMDA, N-methyl-D-aspartate.

###### 

Mapping the IEEE standard association P1906.1 framework to the function of a generic neuron cell

  OSI model   Protocol stack function                                                                                              Mapping to the function of neuron cell               Protocol stack function   Mapping to the function of neuron cell                                                                                                  Protocol stack function   Mapping to the function of neuron cell
  ----------- -------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------- ------------------------- --------------------------------------------------------------------------------------------------------------------------------------- ------------------------- ----------------------------------------
  Network                                                                                                                                                                               Field                     Polarity of MTs with designated minus ends and plus ends generating a field and guiding the molecular motors in a specified direction                             
  Data link   Specificity                                                                                                          Receptors for DCV-BDNF molecules on kinesins                                                                                                                                                                                                     
  Motion      Self-propelled active transport of BDNF by molecular motor proteins on MT tracks by walking and directed diffusion                                                                                                                                                                                                                                                    
  Physical    Message carrier                                                                                                      Molecular motor-vesicle cargo loaded with DCV-BDNF   Perturbation              Stimuli producing Ca^2+^ influx through internal and external sources and controlling the number of DCV-BDNF cargo molecules carried                              

**Abbreviations:** OSI, Open Systems Interconnection; DCV, dense core vesicle; BDNF, brain-derived neurotrophic factor; MT, microtubule; IEEE, Institute of Electrical and Electronics Engineers.

###### 

Notations used in the optimization problem

  Sl no   Notation       Meaning
  ------- -------------- ----------------------------------------------------------------------------------------------------------------
  1       *tot_arr*      Total number of DCV-BDNF molecules generated by the source (transmitter)
  2       *M~total_j~*   Total number of DCV-BDNF molecules accumulating at the end of *j*th stage of MTs
  3       *i*            Index variable for parallel MT gates; *i*∈\[1, *m*\]
  4       *j*            Index variable denoting the stage of MT segments; *j*∈\[1, *n*\]
  5       *r~ij~*        Clearance rate of cargos in the *i*th MT gate of the *j*th stage; *i*∈\[1, *m*\] and *j*∈\[1, *n*\]
  6       *c~ij~*        Capacity of DCV-BDNF molecules in the *i*th MT gate of the *j*th stage; *i*∈\[1, *m*\] and *j*∈\[1, *n*\]
  7       *x~ij~*        Number of DCV-BDNF molecules loaded in the *i*th MT gate of the *j*th stage; *i*∈\[1, *m*\] and *j*∈\[1, *n*\]
  8       *α*            Network (neuron cell) complexity parameter (≥2)

**Abbreviations:** DCV, dense core vesicle; BDNF, brain-derived neurotrophic factor; MT, microtubule; SI, serial number.

###### 

Attributes and units for metric

  Sl no   Attribute                                                                     Unit
  ------- ----------------------------------------------------------------------------- -----------------
  1       Unrealized BDNF percentage (*P~b~*)                                           \%
  2       Average traversal time per message carrier (DCV-BDNF molecules) (*T~trav~*)   Second
  3       Diffusive flux (*J~diff~*)                                                    Mol/m^2^ second
  4       Active network programmability (ANP)                                          Mol/m^2^ second
  5       Axonal MT gate quality factor (*Q~i~*)                                        Nanosecond

**Abbreviations:** DCV, dense core vesicle; BDNF, brain-derived neurotrophic factor; MT, microtubule.

###### 

Data set used in simulation

  SI no   Attributes                                                                                                                                   Values                    Units                       Data sources
  ------- -------------------------------------------------------------------------------------------------------------------------------------------- ------------------------- --------------------------- -----------------------------------------------------------
  1       Ion incoming rate from VGCC channel                                                                                                          7--8                      Ions/nanosecond             Masashi and Berger[@b70-ijn-13-3105]
  2       Ion incoming rate from AMPA, NMDA channels                                                                                                   4--5                      Ions/nanosecond             Tempia et al[@b71-ijn-13-3105]
  3       Length of MT (l) (in range)                                                                                                                  1--10                     Micrometer                  Lodish et al[@b72-ijn-13-3105]
  4       Diameter of MT (Dim)                                                                                                                         25                        Nanometer                   Lodish et al[@b72-ijn-13-3105]
  5       Cargo (vesicle) velocity (assuming only one type of Klp; all cargoes \[vesicles\] have same velocity) (v~c~)                                 800                       Nanometer/second            Riehlman et al[@b29-ijn-13-3105]
  6       Diffusion coefficient of Ca^2+^ (D)                                                                                                          5.3×10^−10^               m^2^/second                 Donahue and Abercrombie[@b34-ijn-13-3105]
  7       Ion incoming rate due to CICR                                                                                                                18--22                    Ions/nanosecond             Assumed to be 2.5--3 higher than number stated in Sl no 1
  8       Ion incoming rate through a Aβ1-42 pore                                                                                                      0.15×10^−3^--1.5×10^−3^   Ions/nanosecond             Demuro et al[@b16-ijn-13-3105]
  9       DCV-BDNF incoming rate                                                                                                                       20                        Molecules/nanosecond        Assumption
  10      Cargo (vesicle) capacity (max no of DCV-BDNF molecules one cargo \[vesicle\] can accommodate)                                                50--70                    Molecules/cargo (vesicle)   Assumption
  11      No of parallel MTs per level                                                                                                                 4                         In numbers                  Assumption
  12      No of such levels in one neuron                                                                                                              4                         In numbers                  Assumption
  13      BDNF loading rate at MT minus end (taken equal to one cargo \[vesicle\] capacity)                                                            50--70                    Molecules/nanosecond        Assumption
  14      BDNF unloading rate at MT plus end (taken equal to one cargo \[vesicle\] capacity)                                                           50--70                    Molecules/nanosecond        Assumption
  15      Buffer size at plus end and minus end of MT (this range of values is chosen optimally to make leakage during the MT assembly less than 4%)   10,000--12,000            In numbers                  Assumption
  16      Observation time step                                                                                                                        1                         Seconds                     Assumption

**Abbreviations:** VGCC, voltage-gated Ca^2+^ channel; AMPA, α-amino-3-hydroxy-5-methyl-isoxazolepropionic acid; NMDA, N-methyl-D-aspartate; MT, microtubule; CICR, calcium induced calcium release; Aβ1, amyloid beta oligomer; DCV, dense core vesicle; BDNF, brain-derived neurotrophic factor.

###### 

Parameters of axonal MT gates used in simulation

  SI no   Attributes                                                                                                                 Range of values    Units                  Data sources
  ------- -------------------------------------------------------------------------------------------------------------------------- ------------------ ---------------------- ------------------
  1       Capacity of DCV-BDNF molecules in the *i*th MT gate of the *j*th stage; *i*∈\[1, *m*\] and *j*∈\[1, *n*\] (*c~ij~*)        25--55             Molecules              Assumption
  2       Clearance rate of cargos in the *i*th MT gate of the *j*th stage; *i*∈\[1, *m*\] and *j*∈\[1, *n*\] (*r~ij~*)              15--35             Molecules/nanosecond   Assumption
  3       Number of DCV-BDNF molecules loaded in the *i*th MT gate of the *j*th stage; *i*∈\[1, *m*\] and *j*∈\[1, *n*\] (*x~ij~*)   To be determined   In numbers             To be determined

**Abbreviations:** DCV, dense core vesicle; BDNF, brain-derived neurotrophic factor; MT, microtubule.

###### 

Optimized values of clearance of DCV-BDNF molecules through MT gates and calculated metrics

  Source output and gate input (DCV-BDNF)   Source output (Ca^2+^)   Gate configuration   Metrics                                                             
  ----------------------------------------- ------------------------ -------------------- --------- ---- ---- ------- ------- -------- -------------- ------- -------
  317,790                                   294,900                  658,870              1st       25   18   2,156   5.35    94.65    3.11×10^--5^   5,034   6,962
  2nd                                       31                       26                   1,963                                                               
  3rd                                       32                       19                   2,750                                                               
  4th                                       40                       31                   1,576                                                               
  5th                                       50                       32                   487                                                                 
  341,050                                   319,800                  680,190              1st       33   50   932     3.93    96.07    3.10×10^--5^   6,921   6,962
  2nd                                       27                       19                   2,001                                                               
  3rd                                       52                       35                   2,044                                                               
  4th                                       48                       31                   92                                                                  
  5th                                       28                       16                   2,477                                                               
  381,348                                   356,930                  774,360              1st       33   31   1,899   4.985   95.015   2.32×10^--5^   4,719   2,435
  2nd                                       31                       27                   1,646                                                               
  3rd                                       36                       19                   1,962                                                               
  4th                                       48                       33                   1,298                                                               
  5th                                       25                       18                   2,546                                                               
  6th                                       30                       29                   1,415                                                               
  409,260                                   365,312                  823,200              1st       31   25   1,820   6.57    93.43    2.19×10^--5^   5,348   2,369
  2nd                                       38                       21                   12                                                                  
  3rd                                       25                       17                   2,826                                                               
  4th                                       30                       29                   1,686                                                               
  5th                                       48                       35                   2,425                                                               
  6th                                       26                       23                   2,274                                                               

**Abbreviations:** DCV, dense core vesicle; BDNF, brain-derived neurotrophic factor; MD, message deliverability.

###### 

Effect of varying calcium levels on overall percentage of DCV-BDNF unrealized

  Calcium concentration levels   Calcium concentration values (nM)   Source output (Ca^2+^)   Source output and gate input (BDNF)   MT gate configuration   Metrics                              
  ------------------------------ ----------------------------------- ------------------------ ------------------------------------- ----------------------- --------- ---- ---- ------- -------- --------
  Nominal value                  41.5                                774,360                  381,348                               356,930                 1st       33   31   1,899   4.985    95.015
  2nd                            31                                  27                       1,646                                                                                              
  3rd                            36                                  19                       1,962                                                                                              
  4th                            48                                  33                       1,298                                                                                              
  5th                            25                                  18                       2,546                                                                                              
  6th                            30                                  29                       1,415                                                                                              
  Moderate value                 77.8                                1,648,758                404,610                               287,800                 1st       33   31   1,532   11.746   88.254
  2nd                            31                                  27                       1,327                                                                                              
  3rd                            36                                  19                       1,582                                                                                              
  4th                            48                                  33                       1,047                                                                                              
  5th                            25                                  18                       2,053                                                                                              
  6th                            30                                  29                       1,141                                                                                              
  Dramatic level                 308                                 3,337,080                360,420                               111,263                 1st       33   31   592     32.93    67.07
  2nd                            31                                  27                       513                                                                                                
  3rd                            36                                  19                       612                                                                                                
  4th                            48                                  33                       405                                                                                                
  5th                            25                                  18                       794                                                                                                
  6th                            30                                  29                       442                                                                                                

**Abbreviations:** BDNF, brain-derived neurotrophic factor; MT, microtubule; MD, message deliverability.

###### 

Calcium ion generation rates for each of the channels in the absence or presence of AβOs

  Calcium channel   Ca^2+^ ion generation rate (ions/ns) under nominal conditions versus AβO influenced moderate or dramatic increase in calcium levels            
  ----------------- ------------------------------------------------------------------------------------------------------------------------------------- -------- ---------
  VGCC              7--8                                                                                                                                  32--37   43--45
  AMPA              4--5                                                                                                                                  16--20   29--34
  NMDA              4--5                                                                                                                                  16--20   29--34
  RyR               18--22                                                                                                                                30--50   85--108

**Abbreviations:** VGCC, voltage-gated Ca^2+^ channel; AMPA, α-amino-3-hydroxy-5-methyl-isoxazolepropionic acid; NMDA, N-methyl-D-aspartate; RyR, ryanodine receptor; AβO, amyloid beta oligomer.

###### 

Effect of Aβ1-42 oligomeric pores on Ca^2+^ levels and unrealized DCV-BDNF percentage in the absence of membrane calcium channels

  Internal diameter of AβO pore   Rate of influx of Ca^2+^ ions through a single pore (ions/ns)   Percentage of unrealized DCV-BDNF                 
  ------------------------------- --------------------------------------------------------------- ----------------------------------- ------ ------ ------
  Small (2--3 nm)                 0.15×10^−3^                                                     3.99                                4.08   4.22   4.47
  Large (5--6 nm)                 1.5×10^−3^                                                      4.15                                4.29   4.43   5.4

**Note:** n = number of pores.

**Abbreviations:** DCV, dense core vesicle; BDNF, brain-derived neurotrophic factor.

###### 

Impact of calcium channel influx on unrealized DCV-BDNF percentage under moderate Ca^2+^ levels when each receptor is blocked selectively in the absence of AβOs

  Calcium receptors   Resultant calcium ion gen rate (ions/ns)   Source output and gate input (BDNF)   DCV-BDNF loss at MT   DCV-BDNF total loss in transport   Metrics                                       
  ------------------- ------------------------------------------ ------------------------------------- --------------------- ---------------------------------- --------- --------- -------- -------- ------- -----------
  Off                 On                                         On                                    On                    30                                 308,880   266,182   13,574   20,059   6.49    4.9--7.2
  On                  Off                                        On                                    On                    33                                 323,610   269,884   23,687   30,249   9.35    5.6--11.8
  On                  On                                         Off                                   On                    33                                 311,209   263,108   19,875   26,251   8.43    5.6--11.8
  On                  On                                         On                                    Off                   18                                 309,268   272,698   10,868   17,497   5.66    4.6--6.1
  On                  On                                         On                                    On                    38                                 327,872   267,227   34,380   40,879   12.47   7.8--13.8

**Abbreviations:** VGCC, voltage-gated Ca^2+^ channel; AMPA, α-amino-3-hydroxy-5-methyl-isoxazolepropionic acid; NMDA, N-methyl-D-aspartate; RyR, ryanodine receptor; MT, microtubule; DCV, dense core vesicle; BDNF, brain-derived neurotrophic factor.

###### 

Impact of calcium channel flow in the presence of AβOs on unrealized DCV-BDNF percentage when each channel is blocked selectively

  Calcium channels   Resultant calcium ion gen rate (ions/ns)   Source output and gate input (BDNF)   DCV-BDNF loss at MT gates   DCV-BDNF total loss in transport   Metrics                               
  ------------------ ------------------------------------------ ------------------------------------- --------------------------- ---------------------------------- --------- --------- -------- -------- -------
  Off                On                                         On                                    On                          150                                297,645   251,082   25,985   45,525   15.29
  On                 Off                                        On                                    On                          165                                309,264   240,815   47,311   66,041   21.35
  On                 On                                         Off                                   On                          165                                312,759   245,699   45,992   65,087   20.81
  On                 On                                         On                                    Off                         90                                 281,364   264,000   1,588    22,174   7.88
  On                 On                                         On                                    On                          190                                333,684   240,234   71,614   90,261   27.05

**Abbreviations:** VGCC, voltage-gated Ca^2+^ channel; AMPA, α-amino-3-hydroxy-5-methyl-isoxazolepropionic acid; NMDA, N-methyl-D-aspartate; RyR, ryanodine receptor; MT, microtubule; DCV, dense core vesicle; BDNF, brain-derived neurotrophic factor.
